124
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Multiple Faces of Eyelid Involvement in Sarcoidosis

, MD, , MD, , MD, PhD & , MD, PhD
Pages 925-929 | Received 27 Jun 2020, Accepted 16 Nov 2020, Published online: 19 Feb 2021
 

ABSTRACT

Purpose

To report three cases of eyelid involvement by sarcoidosis. In one of them, it mimicked a malignant lesion.

Methods

Retrospective case reports.

Results

A 73-year-old man presented with destruction of the left lower eyelid for 2 years. He had granulomatous uveitis in the left eye. Chest CT scan showed parenchymal abnormalities that could correspond to sarcoidosis. Skin biopsy revealed noncaseating granuloma. Oral and topical corticosteroids resulted in improvement of the condition. A 72-year-old female patient presented with cutaneous infiltration of the left upper eyelid for 1 month. Biopsy was consistent with sarcoidosis. Endobronchial biopsies showed interstitial fibrosis. Oral prednisone improved the condition. A 65-year-old female patient presented with edema of the right upper eyelid for 2 months. Full-thickness biopsy showed granuloma without necrosis. There was an improvement with oral steroid.

Conclusion

Although eyelid involvement in sarcoidosis is uncommon, different forms of presentation, including destructive lesions, can be observed.

Declaration of interest

None of the authors has any conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.